How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

687 results for

Cardiovascular rehabilitation

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

601. Diagnosis and Treatment of Peripheral Artery Diseases

. Victor Aboyans, Department of Cardiology, Dupuytren University Hospital, 2 Martin Luther King ave., Limoges 87042, France. Tel:+33 555 056 310, Fax:+33 555 056 384, Email: vaboyans@ucsd.edu. ESC entities having participated in the development of this document: Associations: European Association for Cardiovascular Prevention and Rehabilitation (EACPR), European Association of Percutaneous Cardiovascular Interventions (EAPCI), Heart Failure Association (HFA). Working Groups: Atherosclerosis (...) and Vascular Biology, Thrombosis, Hypertension and the Heart, Peripheral Circulation, Cardiovascular Pharmacology and Drug Therapy, Acute Cardiac Care, Cardiovascular Surgery. Councils: Cardiology Practice, Cardiovascular Imaging, Cardiovascular Nursing and Allied Professions, Cardiovascular Primary Care. The content of these European Society of Cardiology (ESC) Guidelines has been published for personal and educational use only. No commercial use is authorized. No part of the ESC Guidelines may

2011 European Society of Cardiology

602. Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation

Cardiovascular Interventions, European Association for Cardiovascular Prevention & Rehabilitation. Working Groups: Working Group on Cardiovascular Pharmacology and Drug Therapy, Working Group on Thrombosis, Working Group on Cardiovascular Surgery, Working Group on Acute Cardiac Care, Working Group on Atherosclerosis and Vascular Biology, Working Group on Coronary Pathophysiology and Microcirculation. Councils: Council on Cardiovascular Imaging, Council for Cardiology Practice. The content of these European (...) activated clotting time ACUITY Acute Catheterization and Urgent Intervention Triage strategY AF atrial ?brillation AHA American Heart Association APPRAISE Apixaban for Prevention of Acute Ischemic Events aPTT activated partial thromboplastin time ARB angiotensin receptor blocker ARC Academic Research Consortium ATLAS Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Aspirin With or Without Thienopyridine Therapy in Subjects with Acute Coronary Syndrome BARI-2D Bypass Angioplasty

2011 European Society of Cardiology

603. Guidelines for the management of dyslipidaemias

Guidelines for the management of dyslipidaemias ESC/EAS GUIDELINES ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Developed with the special contribution of: European Association for Cardiovascular Prevention & Rehabilitation † Authors/Task Force Members: Z ? eljko Reiner * (ESC Chairperson) (Croatia) Alberico L. Catapano * (EAS Chairperson (...) , Italy. Tel: +39 02 5031 8302, Fax:+39 02 5031 8386, Email: Alberico.Catapano@unimi.it † Other ESC entities having participated in the development of this document: Associations: Heart Failure Association. Working Groups: Cardiovascular Pharmacology and Drug Therapy, Hypertension and the Heart, Thrombosis. Councils: Cardiology Practice, Primary Cardiovascular Care, Cardiovascular Imaging. The content of these European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS

2011 European Society of Cardiology

604. Macular degeneration - age-related

with conflicting evidence as to their effects, and if they do increase the risk, the risk is small. These include: Hypertension. There is no evidence that treatments to lower blood pressure can prevent the development or progression of the disease. Cardiovascular disease. Evidence is conflicting as to whether statins have a role in preventing or delaying the onset or progression of AMD. Regular aspirin use. A consensus document from the American Academy of Ophthalmology states that, 'the current preferred (...) for geographic atrophy is limited and consists mainly of counselling, smoking cessation, visual rehabilitation, and nutritional supplements to reduce the risk of progression in those expected to benefit. Treatments for neovascular age-related macular degeneration (AMD): Anti-angiogenic therapies: Vascular endothelial growth factor (VEGF) is a pro-angiogenic growth factor that also stimulates vascular permeability and has a major role in the pathology of neovascular AMD. Drug inhibition of VEGF has become

2016 NICE Clinical Knowledge Summaries

605. Sprains and strains

criteria Audit criteria No audit criteria were found during the review of this topic. QOF indicators QOF indicators No QOF indicators were found during the review of this topic. QIPP - Options for local implementation QIPP - options for local implementation Non-steroidal anti-inflammatory drugs (NSAIDs) Review the appropriateness of NSAID prescribing widely and on a routine basis, especially in people who are at higher risk of both gastrointestinal and cardiovascular morbidity and mortality (...) . CKS has not recommended referral of all muscle strains, because conservative management will result in a good outcome in most cases [ ]. However, the expert opinion of previous reviewers of this CKS topic is that appropriate rehabilitation reduces the likelihood of a further strain and/or residual symptoms, so referral to physiotherapy may be justified. Prevention of further strains and sprains What should I advise on preventing further strains and sprains? Advise that the person should: Take care

2016 NICE Clinical Knowledge Summaries

606. Olecranon bursitis

in people who are at higher risk of both gastrointestinal (GI) and cardiovascular (CV) morbidity and mortality (e.g. older patients). If initiating an NSAID is obligatory, use ibuprofen (1200 mg per day or less) or naproxen (1000 mg per day or less). Use the lowest effective dose and the shortest duration of treatment necessary to control symptoms. Review patients currently prescribed NSAIDs. If continued use is necessary, consider changing to ibuprofen (1200 mg per day or less) or naproxen (1000 mg per

2016 NICE Clinical Knowledge Summaries

607. Greater trochanteric pain syndrome (trochanteric bursitis)

, and key randomized controlled trials published since the last revision of this topic. Minor changes to the recommendations on management of greater trochanteric pain syndrome have been made. Previous changes Previous changes July 2013 — minor update. Update to the text to reflect new recommendations by the MHRA regarding diclofenac Diclofenac: new contraindications and warnings after a Europe-wide review of cardiovascular safety, 2013, Medicines and Healthcare products Regulatory Agency . February (...) of General Practice. 57 ( 541 ), 655 - 661 . [ ] Mallow, M. and Nazarian, L.N. ( 2014 ) Greater trochanteric pain syndrome diagnosis and treatment. Physical medicine and rehabilitation clinics of North America. May 2012, 25 ( 2 ), 279 - 289 . [ ] Novatnack, E.S., Protzman, N.M. and Weiss, C.B. ( 2015 ) Primary septic greater trochanteric bursitis. Journal of Global Infectious Diseases. April-June 7 ( 2 ), 93 - 94 . Diane Reid ( 2015 ) The management of greater trochanteric pain syndrome: a systematic

2016 NICE Clinical Knowledge Summaries

608. Hepatitis A

if they are severely unwell. If admission is not needed: Providing symptomatic supportive care for pain, nausea, or itch if needed. Notifying the local Health Protection Unit promptly — if an outbreak is suspected, or the person is a food handler, notify immediately. Providing information and advice about hepatitis A, including the need to avoid alcohol during the acute illness. Offering referral to a genito-urinary medicine clinic or drug rehabilitation centre, if appropriate. Monitoring liver function tests (...) No audit criteria were found during the review of this topic. QOF indicators QOF indicators No QOF indicators were found during the review of this topic. QIPP - Options for local implementation QIPP - Options for local implementation Non-steroidal anti-inflammatory drugs (NSAIDs) Review the appropriateness of NSAID prescribing widely and on a routine basis, especially in people who are at higher risk of both gastrointestinal (GI) and cardiovascular (CV) morbidity and mortality (e.g. older patients

2016 NICE Clinical Knowledge Summaries

609. Pre-patellar bursitis

drugs (NSAIDs) Review the appropriateness of NSAID prescribing widely and on a routine basis, especially in people who are at higher risk of both gastrointestinal (GI) and cardiovascular (CV) morbidity and mortality (e.g. older patients). If initiating an NSAID is obligatory, use ibuprofen (1200 mg per day or less) or naproxen (1000 mg per day or less). Use the lowest effective dose and the shortest duration of treatment necessary to control symptoms. Review patients currently prescribed NSAIDs (...) . The Physican and Sportsmedicine. 28 ( 3 ), 40 - 52 . [ ] MHRA ( 2015 ) Guidance on cox-2 selective inhibitors and non-steroidal anti-inflammatory drugs (NSAIDs): cardiovascular safety. MHRA. . [ ] NICE ( 2014 ) Osteoarthritis. Care and management in adults (NICE guideline). Clinical guideline 177. National Institute for Health and Care Excellence. . [ ] NICE ( 2016 ) Medicines optimisation: key therapeutic topics. National Institute for Health and Care Excellence. . Reid CR, Bush PM, Cummings NH, McMullin

2016 NICE Clinical Knowledge Summaries

610. Psychosis and schizophrenia

, are conditions in which psychosis occurs for a significant period of time. They may also be associated with negative symptoms (for example emotional blunting, reduced speech, loss of motivation, self neglect, and social withdrawal). With treatment, psychotic symptoms may resolve fully, recur intermittently with periods of remission between, or persist. Complications include: An increased risk of premature death due to an increased risk of suicide, cardiovascular disease, and type 2 diabetes. Difficulties (...) . Ensure optimal control of psychotic symptoms by: Referring all people at risk of developing a psychotic disorder for specialist assessment and management. Referring all people with suspected psychosis or schizophrenia for specialist assessment and management. Referring all people experiencing a relapse of psychosis or schizophrenia for specialist assessment and management. Manage raised cardiovascular disease risk in people with psychosis through: Annual assessment of cardiovascular disease risk

2016 NICE Clinical Knowledge Summaries

611. Temporomandibular disorders (TMDs)

for local implementation QIPP - Options for local implementation Nonsteroidal anti-inflammatory drugs (NSAIDs) Review the appropriateness of NSAID prescribing widely and on a routine basis, especially in people who are at higher risk of both gastrointestinal (GI) and cardiovascular (CV) morbidity and mortality (for example, older people). If an NSAID is needed, use ibuprofen (1200 mg per day or less) or naproxen (1000 mg per day or less). Use the lowest effective dose and the shortest duration

2016 NICE Clinical Knowledge Summaries

612. Plantar fasciitis

criteria Audit criteria No audit criteria were found during the review of this topic. QOF indicators QOF indicators No QOF indicators were found during the review of this topic. QIPP - Options for local implementation QIPP - Options for local implementation Non-steroidal anti-inflammatory drugs (NSAIDs) Review the appropriateness of NSAID prescribing widely and on a routine basis, especially in people who are at higher risk of both gastrointestinal (GI) and cardiovascular (CV) morbidity and mortality (...) . [ ] Foye,P.M. ( 2013 ) Physical medicine and rehabilitation for plantar fasciitis. eMedicine. Medscape. . [ ] Goff,J.D. and Crawford,R. ( 2011 ) Diagnosis and treatment of plantar fasciitis. American Family Physician. 84 ( 6 ), 676 - 682 . [ ] Hawke,F., Burns,J., Radford,J.A. and du Toit,V. ( 2008 ) Custom-made foot orthoses for the treatment of foot pain (Cochrane Review). The Cochrane Library. John Wiley & Sons, Ltd . [ ] Hyland,M.R., Webber-Gaffney,A., Cohen,L. and Lichtman,P.T. ( 2006 ) Randomized

2015 NICE Clinical Knowledge Summaries

613. Depression

of adaptive mechanisms to stressors. Chronic comorbidities such as diabetes, chronic obstructive pulmonary disease, cardiovascular disease and especially people with chronic pain syndromes. A past head injury, including hypopituitarism following trauma [ ; ]. People at high risk of depression Who is at high risk of depression? People who are at high-risk of depression include anyone with [ ; ]: A history of depression, suicide attempt, or any form of abuse (sexual, physical, or substance). Significant

2015 NICE Clinical Knowledge Summaries

614. Depression in adults with chronic physical health problem: recognition and management

care on physical health outcomes for patients with moderate to severe depression and a chronic physical health problem 39 4.6 The effectiveness of physical rehabilitation programmes for patients with a chronic physical health problem and depression 40 4.7 The efficacy of counselling compared with low-intensity cognitive and behavioural interventions and treatment as usual in the treatment of depression in patients with a chronic physical health problem 41 5 Other versions of this guideline 43 (...) physical health problems can greatly increase the risk of depression in people with physical illness, and depression can also exacerbate the pain and distress associated with physical illnesses and adversely affect outcomes, including shortening life expectancy. Furthermore, depression can be a risk factor in the development of a range of physical illnesses, such as cardiovascular disease. When a person has both depression and a chronic physical health problem, functional impairment is likely

2009 National Institute for Health and Clinical Excellence - Clinical Guidelines

615. Management of hip fracture in older people

relief 22 8.2 Oxygen 22 8.3 Fluid and electrolyte balance 23 8.4 Delirium 23 8.5 Early mobilisation 23 8.6 Constipation 23 8.7 Urinary catheterisation 24 9 rehabilitation and discharge 25 9.1 Early assessment 25 9.2 Rehabilitation 25 9.3 Discharge 26 9.4 Discharge management 28 10 provision of information 29 10.1 Providing information and support 29 10.2 Sources of further information 29 10.3 Checklist for provision of information 31 11 implementing the guideline 33 11.1 Resource implications 33 11.2 (...) loss of prior full mobility; for some frailer patients the permanent loss of the ability to live at home. For the frailest of all it may bring pain, confusion and disruption to complicate an already distressing illness. Overall, one-year mortality after hip fracture is high, at around 30%, though only one third of that is directly attributable to the fracture. 1 Despite significant improvements in both surgery and rehabilitation in recent decades, hip fracture remains, for patients and their carers

2009 SIGN

616. Canadian best practice recommendations for stroke care

unit care . . . . . . . . . . . . . . . . . . . . . . . . . . . . E45 4.2 Components of acute inpatient care . . . . . . . . . . . E48 5 5: : S St tr ro ok ke e r re eh ha ab bi il li it ta at ti io on n a an nd d c co om mm mu un ni it ty y r re ei in nt te eg gr ra at ti io on n E52 5.1 Initial stroke rehabilitation assessment . . . . . . . . . E52 5.2 Provision of inpatient stroke rehabilitation . . . . . . E54 5.3 Components of inpatient stroke rehabilitation . . E56 5.4 Outpatient (...) and community-based rehabilitation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E58 5.5 Follow-up and community reintegration . . . . . . . . E61 6 6: : S Se el le ec ct te ed d t to op pi ic cs s i in n s st tr ro ok ke e m ma an na ag ge em me en nt t E63 6.1 Dysphagia assessment . . . . . . . . . . . . . . . . . . . . . . . E63 6.2 Identification and management of post-stroke depression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E65 6.3 Vascular cognitive impairment

2009 CPG Infobase

617. End-of-Life Care During the Last Days and Hours

cancer now exceeding deaths from cardiovascular diseases. These two diseases now account for almost 60% of all deaths in Canada (Statistics Canada, 2007a; Statistics Canada, 2007b). The prevalence of chronic disease in older adults, combined with an aging population, means that providing high-quality care specific to the needs of individuals at the end of life and their families is imperative. In her report entitled Raising the Bar, Carstairs (2010) highlights issues that face stakeholders

2011 Registered Nurses' Association of Ontario

619. Preventing and Mitigating Nurse Fatigue in Health Care

DIETRICH RPN, cRTWc , cDMP , McVP , MHS Rehabilitation Consultant Cascade Disability Management Inc., Waterloo, Ontario ROSE GASS RN, ENc(c), BA, MHST Director, Emergency and Respiratory Norfolk General Hospital, Simcoe, Ontario JULIE GREGG MADED, RN Policy Consultant College of Registered Nurses of Nova Scotia, Halifax, Nova Scotia LINDA HASLAM-STROUD RN President Ontario Nurses’ Association, T oronto, OntarioPreventing and Mitigating Nurse Fatigue in Health Care BACKGROUND 13 BEST PRACTICE GUIDELINES (...) the likelihood of inadequate or poor sleep, anxiety, depression and absenteeism. 46 Work-related fatigue has also been associated with higher rates of injury, divorce, domestic abuse and chemical impairment. 47 Sleep durations of four hours or less have also been associated with obesity, cardiovascular disease, diabetes and depression, as well as other psychiatric disorders, while sleep deprivation and extended work hours have been associated with driving impairment. 44 Nurse fatigue is often associated

2011 Registered Nurses' Association of Ontario

620. Secondary Prevention For Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Guideline Update

- ids/lipoproteins/dyslipidemia; physical activity/exercise/exercise training; weight management/overweight/obesity; type 2 diabe- tes mellitus management; antiplatelet agents/anticoagulants; renin/angiotensin/aldosterone system blockers;-blockers; in- ?uenza vaccination; clinical depression/depression screening; and cardiac/cardiovascular rehabilitation. Additional searches cross-referenced these topics with the subtopics of clinical trials, secondary prevention, atherosclerosis, and coronary (...) ) Cardiac rehabilitation Class I 1. All eligible patients with ACS or whose status is immediately post coronary artery bypass surgery or post-PCI should be referred to a comprehensive outpatient cardiovascular rehabilitation program either prior to hospital discharge or during the ?rst follow-up of?ce visit (55,154,161,163). (Level of Evidence: A) 2. All eligible outpatients with the diagnosis of ACS, coronary artery bypass surgery or PCI (Level of Evidence: A) (55,154,155,161), chronic angina (Level

2011 American College of Cardiology

Guidelines

Guidelines – filter by country